Friday, September 21, 2018

New cancer clinical trial: A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA

Published on: September 20, 2018 at 12:00PM
Condition:   Colorectal Cancer With Liver Metastases
Intervention:  
Sponsor:   Fudan University
Recruiting
https://ift.tt/2QO2rVR

No comments:

Post a Comment